Uptake of Supportive Care Low for Patients With Advanced Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 28, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, Feb. 28, 2025 -- Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive care, according to a study published online Feb. 21 in JAMA Health Forum.

Youngmin Kwon, Ph.D., from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues examined contemporary patterns of end-of-life care among patients with advanced cancer in a retrospective cohort study to determine whether efforts to improve end-of-life care among these patients in the last decade have had an impact. The study included 33,744 fee-for-service Medicare decedents aged 66 years or older who were originally diagnosed with distant-stage breast, prostate, pancreatic, or lung cancers and died between 2014 and 2019.

The researchers observed an increase in the mean number of acute care visits from six months before death to the month of death (from 14.0 to 46.2 per 100 person-months), as well as increases in hospice use (from 6.6 to 73.5 per 100 person-months), palliative care (from 2.6 to 26.1 per 100 person-months), and advanced care planning (from 1.7 to 12.8 per 100 person-months). Any indicator of potentially aggressive care was experienced by 45.0 percent of decedents in the last 30 days of life.

"We found that many patients continue to receive potentially aggressive interventions at end of life at the expense of supportive care services," the authors write. "To make meaningful improvements in the quality of end-of-life care, a multifaceted approach that addresses patient, physician, and system-level factors associated with persistent patterns of potentially aggressive care will be required."

One author disclosed ties to Pfizer.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords